ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0155

Effect Modification of Cigarette Smoking on the Relationship between Post Traumatic Stress Disorder and Rheumatoid Arthritis Risk

Kelsey Coziahr1, Harlan Sayles1, Tate Johnson1, Joshua Baker2, Punyasha Roul3, Grant Cannon4, Gary Kunkel5, Bryant England1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Pennsylvania, Philadelphia, PA, 3UNMC, Omaha, NE, 4University of Utah and Salt Lake City VA, Salt Lake City, UT, 5Salt Lake City VA, Salt Lake City, UT

Meeting: ACR Convergence 2025

Keywords: Anti-CCP, Epidemiology, psychological status, rheumatoid arthritis, Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 26, 2025

Title: (0145–0174) Epidemiology & Public Health Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Post-traumatic stress disorder (PTSD) is associated with increased systemic inflammation that may increase the risk of developing autoimmune disorders such as rheumatoid arthritis (RA). The prevalence of cigarette smoking, an established risk factor in RA, is substantially higher in patients with PTSD than in the general population. We aimed to quantify the association between PTSD and the risk of developing RA in U.S. veterans, examining whether this association is confounded or modified by smoking.

Methods: We conducted a nested, case-control study using national Veteran Health Administration data from 2006-2019, identifying patients with incident RA (≥2 diagnostic codes, rheumatologist diagnosis, positive autoantibody or DMARD fill, plus ≥365 days in VA care before a DMARD fill or RA ICD code). Cases were matched to non-RA controls on the date the RA algorithm was fulfilled, at a ratio up to 1:10 by age, sex and year of VA enrollment. PTSD and other mental health disorders (OMH; i.e., bipolar disorder, depression, anxiety and substance use) were identified retrospectively and defined by the presence of ≥2 ICD9/10 codes. Conditional multivariable logistic regression was used to examine the association of PTSD (± OMH) and OMH (without PTSD) with RA, adjusting for race, ethnicity, urban/rural residence, smoking status, and BMI and including an interaction term for RA status and smoking. Based on initial results, additional models were stratified by ever vs. never smoking status and included age, sex, and year of VA enrollment as covariates in addition to those noted. Separate models were used to examine associations in subgroups defined by sex and seropositivity status (RF and/or aCCP).

Results: Patients included in this analysis (n=357,361; n=32,884 with RA) had a mean age of 53 years, 87% were male, and 70% had ever smoked. Among RA cases, 76% were RF or aCCP positive. PTSD, OMH, and smoking were all more frequent in patients with RA than controls (Table 1). In multivariable analyses, there was evidence of a highly significant smoking-PTSD interaction (p< 0.001). In subsequent multivariable analyses stratified by ever smoking status, the association of PTSD (vs. no PTSD or OMH) with RA was higher in never smokers (aOR 1.54; 95% CI 1.41, 1.69) than ever smokers (aOR 1.20; 95% CI 1.16, 1.25). Similar associations, though lower in magnitude, were observed for OMH (Table 2). PTSD-related risk remained quantitatively higher in never vs. ever smokers in subgroups defined by sex and seropositivity with a higher risk observed for seronegative RA (Table 3).

Conclusion: In addition to validating prior reports demonstrating an increased risk of RA attributable to both PTSD and cigarette smoking, these results suggest that the relationship of PTSD with RA disease susceptibility is modified, rather than being confounded, by smoking status with a greater contribution to RA risk in never smokers. PTSD also appears to be more closely associated with the development of seronegative RA. These results highlight a complex relationship between PTSD and OMH with RA development and call for research into how mental health may influence the development of distinct RA phenotypes.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: K. Coziahr: None; H. Sayles: None; T. Johnson: None; J. Baker: None; P. Roul: None; G. Cannon: None; G. Kunkel: None; B. England: Boehringer-Ingelheim, 2, 5; T. Mikuls: Amgen, 2, 5, Merck/MSD, 1, Olatech Therapeutics, 1, UCB, 1.

To cite this abstract in AMA style:

Coziahr K, Sayles H, Johnson T, Baker J, Roul P, Cannon G, Kunkel G, England B, Mikuls T. Effect Modification of Cigarette Smoking on the Relationship between Post Traumatic Stress Disorder and Rheumatoid Arthritis Risk [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/effect-modification-of-cigarette-smoking-on-the-relationship-between-post-traumatic-stress-disorder-and-rheumatoid-arthritis-risk/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-modification-of-cigarette-smoking-on-the-relationship-between-post-traumatic-stress-disorder-and-rheumatoid-arthritis-risk/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology